ALX ONCOLOGY HOLDINGS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.86 USD | -0.06% |
|
+8.08% | +13.23% |
| Apr. 18 | Alx Oncology Holdings Insider Sold Shares Worth $710,195, According to a Recent SEC Filing | MT |
| Apr. 10 | ALX Oncology Reports Positive Data From Ongoing Phase 1/2 Trial of Evorpacept | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 16.87 | 16.87 | 20.00 |
| Spread/Res. | -0.06% | -0.06% | -15.70% |
| Spread/Supp. | +30.80% | +57.28% | +102.64% |
| Support | 12.89 | 10.72 | 8.320 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- ALXO Stock
- Charts ALX Oncology Holdings Inc.
